INFERIOR VENA CAVA FILTER RETRIEVAL 23 MONTH AFTER IMPLANTATION WITH STANDARD SNARE LOOP TECHNIQUE : CASE REPORT

2021 ◽  
pp. 23-24
Author(s):  
Ramanand Prasad Sinha ◽  
Archit Dahiya ◽  
Piyush Joshi ◽  
Ashish Jain

1. Introduction. Pulmonary embolism (PE ) and Deep vein thrombosis (DVT ) continues to be a cause of signicant morbidity and mortality which is also third 1 leading cardiovascular cause of death . If not treated properly it also leads to chronic pulmonary hypertension and cor pulmonale . Once DVT is diagnosed treatmet is required and consist of oral anticoagulation and inferior vena cava interruption via lter placement in patients with contraindication for anticoagulation treatment. In 2003 ,the U.S .Food and Drug Administration (FDA ) cleared retrievable inferior vena cave lters (rIVCFs) for clinical use , after that its uses exponentially increases . In parallel with these trends ,there has been growing awareness of device –related complication including fracture , penetration to adjuscent structure , migration , thrombosis and some time embolisation of fractured segment in heart that leads to cardiac 2 3 peforation , arrhythmia and death . In response , the FDA released safety communication in 2010 and 2014 advocating immediate retrieval of 4 lter once mechanical prophylaxis was no longer uses .However retrieval of lter remained rare with rates reported as low as 8.5 %. . Once lter remain in place for long duration, normal standard snare retrieval technique usually not work and alternative techniques like , Sling technique , 5 Excimer laser and Endobronchial forcep supported methods can be used . But prolong duration of lter implantion always associated with less chance of lter retrieval and associated with multiple complication .

2021 ◽  
pp. 153857442110225
Author(s):  
Haidong Wang ◽  
Zhenhua Liu ◽  
Xiaofei Zhu ◽  
Jianlong Liu ◽  
Libo Man

Background: Inferior vena cava (IVC) filters are commonly used in China to prevent pulmonary embolisms in patients with deep vein thrombosis. However, IVC filter removal is complicated when the filter has penetrated the IVC wall and endovascular techniques usually fail. The purpose of this study was to evaluate the effectiveness and safety of retroperitoneal laparoscopic-assisted retrieval of wall-penetrating IVC filters after endovascular techniques have failed. Patients and Methods: We retrospectively evaluated a series of 8 patients who underwent retroperitoneal laparoscopic-assisted retrieval of a wall-penetrating IVC filter between December 2017 and November 2019. All patients had experienced at least 1 failure with endovascular retrieval before the study. The filters were slanted and the proximal retrieval hooks penetrated the posterior lateral IVC wall in all patients on computed tomography. Demographic information, operation parameters, and complications were recorded and analyzed. All patients were followed up for at least 12 months. Results: The procedure was successful in all patients. The median surgery time was 53.6 ± 12.7 min and the average blood loss was 45.0 ± 13.5 ml. No serious complication occurred during the patients’ hospitalization, which was an average of 6.4 days. The median follow-up time was 15.1 months, and no patient had deep vein thrombosis recurrence. Conclusions: Retroperitoneal laparoscopic-assisted retrieval is a feasible and effective technique, particularly when proximal retrieval hooks penetrate the posterior lateral wall of the IVC after endovascular techniques have failed. To some extent, the development of this technique at our institution has increased the success rate of filter removal and improved patient satisfaction.


2021 ◽  
Vol 16 (6) ◽  
pp. 1548-1551
Author(s):  
Sarah Khoncarly ◽  
Nathaniel Edwards ◽  
James J. Buchino ◽  
Janice D. McDaniel

2017 ◽  
Vol 65 (2) ◽  
pp. e26785 ◽  
Author(s):  
Cristina Tarango ◽  
Riten Kumar ◽  
Manish Patel ◽  
Anne Blackmore ◽  
Patrick Warren ◽  
...  

Author(s):  
Inês Esteves Cruz ◽  
Pedro Ferreira ◽  
Raquel Silva ◽  
Francisco Silva ◽  
Isabel Madruga

Inferior vena cava (IVC) agenesis is a rare congenital abnormality affecting the infrarenal segment, the suprarenal or the whole of the IVC. It has an estimated prevalence of up to 1% in the general population that can rise to 8.7% when abnormalities of the left renal vein are considered. Most IVC malformations are asymptomatic but may be associated with nonspecific symptoms or present as deep vein thrombosis (DVT). Up to 5% of young individuals under 30 years of age with unprovoked DVT are found to have this condition. Regarding the treatment of IVC agenesis-associated DVT, there are no standard guidelines. Treatment is directed towards preventing thrombosis or its recurrence. Low molecular weight heparin and oral anticoagulation medication, in particular vitamin K antagonists (VKAs) are the mainstay of therapy. Given the high risk of DVT recurrence in these patients, oral anticoagulation therapy is suggested to be pursued indefinitely. As far as we know, this is the first case reporting the use of a direct factor Xa inhibitor in IVC agenesis-associated DVT. Given VKA monitoring limitations, the use of a direct Xa inhibitor could be an alternative in young individuals with anatomical defects without thrombophilia, but further studies will be needed to confirm its efficacy and safety.


2020 ◽  
Vol 26 (2) ◽  
pp. 51-55
Author(s):  
Roopa B Mangshetty ◽  
Apurva A B ◽  
Mallikarjun Kobal ◽  
Aishwarya Bijapur ◽  
Kedar Gombi

Deep Vein Thrombosis (DVT) is uncommon in children. We describe a case of DVT in children, highlighting importance of early diagnosis of rare disease. Here we report a case of 10-year-old boy presented with persistent pain and swelling of the left thigh. Detailed investigations led to diagnosis of DVT.


Sign in / Sign up

Export Citation Format

Share Document